invigor medical semaglutide Wegovy® 0.25 mg / 0.5 mL Injection 4 high blood pressure Wegovy - Ivím Health

Staying hydrated and adjusting your diet can often alleviate discomfort

Pre-treatment: Measure morning resting heart rate for 7 days Consider baseline ECG if not done recently Review all medications for cardiac interactions Discuss with physician specifically about the glucagon receptor heart rate effect During treatment: Measure resting heart rate daily during dose escalation Continue at each dose for minimum 6 to 8 weeks before increasing If resting HR exceeds baseline by more than 10 BPM, hold dose If resting HR exceeds 90 BPM at rest consistently, consult physician before any further increases Consider microdosing approach for ultra-gradual escalation Expected timeline: Weeks 1-12: very gradual heart rate change at low doses Weeks 12-30: moderate increase as dose slowly climbs Weeks 30+: stabilization (may occur later than standard protocol due to slower escalation) Protocol 3: monitoring-enhanced approach for data-driven researchers Who this is for: Researchers who want comprehensive data, athletes tracking performance metrics, anyone who finds data reassuring

Per Ridha 2024 (PMID 38874170), the medial cheek fat compartment is among the most affected, producing the flattened cheek and deepened nasolabial fold appearance

However, those who practice healthy lifestyle changes may be able to mitigate weight gain